PulseMedica

PulseMedica is developing the world’s first non-invasive, image-guided treatment (IGT) platform for the diagnosis and treatment of vitreoretinal diseases, with an initial focus on symptomatic vitreous opacities (eye floaters)—a critical and long-standing unmet need in ophthalmology. The platform integrates high-resolution 3D imaging, machine learning-based tracking, and femtosecond laser technology to enable real-time visualization and automated treatment of the posterior segment, providing a safe, effective, and office-based alternative to invasive vitrectomy and non-FDA-approved laser vitreolysis procedures.